Be the new Senior Director, Competitive Intelligence
In a biotech company bonding to discover, design and develop innovative peptide-based medicines
Currently, we are looking for a new Senior Director, Competitive Intelligence in our Søborg Denmark office, who will be a strategic leader responsible for building, leading and executing a best-in-class Competitive Intelligence function. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.
Responsibilities
- Strategy & Leadership – Drive Competitive Intelligence strategy to support planning, investor communications, and product development; act as CI Center of Excellence; manage small team/vendors.
- Market Analysis – Monitor competitors, pipelines, market trends, regulations, partnerships, and emerging technologies; synthesize diverse data into clear insights.
- Event Intelligence – Lead CI at key congresses; track competitor activities and KOL sentiment; deliver rapid, actionable insights to leadership.
- Cross-Functional Impact – Collaborate across teams on category assessments, scenario planning, positioning, TPPs, go/no-go decisions, and business development; maintain external intelligence networks to identify threats/opportunities.
Candidate profile
- Extensive pharma, biotech, VC, or analyst experience across science and business functions (e.g., new product planning, medical affairs, strategic planning, commercial, market analysis) and recent competitive intelligence (CI) experience
- Strong quantitative/data analysis skills; able to translate complex preclinical/clinical data and trial designs and scientific and business dynamics into insights for strategic
- Expertise in obesity and/or cardiovascular–renal metabolism (scientific, medical, or commercial)
- Passion for the science–business interface; adept at engaging in both technical and strategic discussions
- Track record of leading teams and influencing across the product/portfolio lifecycle
- Strategic agility in complex, fast-changing, matrixed environments
- Exceptional analytical, communication, and executive influence skills
- Demonstrated ability to anticipate market shifts and shape strategy
Bonding to innovate
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.
We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.
We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.
The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.
Let’s bond and be bold
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.
To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/
Interested? Please apply no later than September 21, 2025, or as soon as possible. The applications will be reviewed as they come in.
For further information, please contact Kristin Gustafson, Ext_KGustafson@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
